Medical Hypotheses
Volume 56, Issue 2 , Pages 262-272 , February 2001

β-casein A1, ischaemic heart disease mortality, and other illnesses

Received 18 September 2000 ,Accepted 27 October 2000.

References 

    REFERENCES
  1. Kuulasmaa K, Tunstall-Pedoe H, Dobson H. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet. 2000;355:675–687
  2. Seely S. Diet and coronary arterial disease: a statistical study. Int J Cardiology. 1968;20:183–192
  3. Davies DF, Davies JR, Richards MA. Antibodies to reconstituted dried cow’s milk protein in coronary heart disease. J Athero Res. 1969;9:103–107
  4. Bolton-Smith C, Brown CA, Woodward M, Tunsdall-Pedoe H. Milk consumption and the prevalence of CHD in men and women from the Scottish Heart Health study. J Hum Nutr Diet. 1992;5:305–310
  5. Artaud-Wild SM, Connor SL, Sexton G, Connor WE. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. Circulation. 1993;88:2771–2779
  6. Briggs RD, Rubenberg AB, O’Neal RM, Thomas WA, Hartroft WS. Myocardial infarction in patients treated with Sippy and other high-milk diets. An autopsy study of fifteen hospitals in the USA and Great Britain. Circulation. 1960;21:538–542
  7. Biss K, Ho K-J, Mikkelson BS, Lewis L, Taylor CB. Some unique biologic characteristics of the Masai of East Africa. New Engl J Med. 1971;284:694–699
  8. Shaper AG. Cardiovascular studies in the Sambura tribe of Northern Kenya. Am Heart J. 1962;63:437–442
  9. Meade TW, Mellows S, Brozovic M. et al An international and interregional comparison of haemostatic variables in the study of ischaemic heart disease. Int J Epidemiol. 1986;15:331–336
  10. Fujimoto N, Fujimoto N, Matsubayashi K. The risk factors for ischaemic heart disease in Tibetan highlanders. Jpn Heart J. 1989;30:27–34
  11. Cheng TO. Heart disease in Tibet. Lancet. 1989;334:163
  12. Swaisgood HE. Chemistry of the caseins. In:  Fox PF editors. Advanced Dairy Chemistry. London: Elsevier; 1992;
  13. Walstra P, Jenness R. Dairy Chemistry and Physics. New York: John Wiley; 1984; p. 107
  14. Coulon JB, Hurtaud C, Remond B, Verte R. Factors contributing to variation in the proportion of casein in cow’s milk true protein: a review of recent INRA experiments. J Dairy Res. 1998;65:375–387
  15. Aschaffenburg R. Genetic variants of milk proteins: their breed distribution. J Dairy Res. 1968;35:447–460
  16. Jakob E. Genetischer polymorphismus der milchprotein. Parts I, II, Schweiz. Milch Forsch. 1994;23:3–19
  17. Eigel WN, Butler JE, Ernstrom CA. Nomenclature of proteins of cow’s milk. J Dairy Sci. 1984;67:1599–1631
  18. Elliott RB, Hill JP. Method of selecting non-diabetogenic milk or milk products so selected. NZ patent P26462,. 1994;
  19. Elliott RB, Harris DP, Hill JP, Bibby NJ, Wasmuth HE. Type1 (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption. Diabetologia. 1999;42:292–296
  20. Uemura K, Pisa Z. Quarterly trends in cardiovascular disease mortality in industrialized countries since 1950. WHO Statistics. 1988;41:155–178
  21. WHO Tech Report Series 853. 1995;
  22. Strom A, Jensen RA. Mortality from circulatory diseases in Norway 1940–45. Lancet. 1951;126:126–129
  23. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?. Br Med J. 1994;308:367–372
  24. Vartiainen E, Pekkanen J, Koskinen S, Jousilahti P, Salomaa V, Puska P. Do changes in cardiovasclar risk factors explain the increasing socioeconomic difference in mortality from ischaemic heart disease in Finland?. J Epid Com Health. 1998;52:416–419
  25. Rose G. Incubation period of coronary heart disease. Br Med J. 1982;284:1600–1601
  26. Akerblom HK, Ballard DJ, Bauman B. Geographic patterns of childhood insulin-dependent diabetes mellitus. Diabetes. 1988;37:1113–1119
  27. Rewers M, LaPorte R, King H, Tuomilehto J. Trends in the prevalence and incidence of diabetes: insulin-dependent diabetes mellitus in childhood. Wld Hth Stat Quart. 1988;41:179–189
  28. Karvonen M, Tuomilehto J, Libman I, LaPorte R. A review of the recent epidemiological data on the worldwide incidence of Type 1 (insulin-dependent) diabetes mellitus. Diabetologia. 1993;36:883–892
  29. Tan MH, MacLean DR. Epidemiology of diabetes mellitus in Canada. Clin Invest Med. 1995;18:240–246
  30. McLachlan CNS. Food product and process. PCT/NZ 96/00039,. 1996;
  31. Weniger JH, Augustini C. Production characters of German cattle breeds. World Rev Anim Prod. 1967;14:62–64
  32. ECC Facts & Figures, Thames, Ditton, Surrey, Milk Marketing Board, 1977–89
  33. Boing H, Martinez L, Frentzel-Beyme R, Oltersdorf U. Regional nutritional pattern and cancer mortality in the Federal Republic of Germany. Nutr & Cancer. 1985;7:121–130
  34. Greiser E, Joeckel KH, Giersepen K, Maschewsky-Schneider U, Zachial M. Cardiovascular disease risk factors, CHD morbidity and mortality in the FRG. Inter J Epid. 1989;18:S118–S124
  35. Ovcarov VK, Bystrova VA. Present trends in mortality in the age group 35–64 in selected developed countries between 1950–1973. WHO Annual Statistics. 1978;3:208–313
  36. Evans AE, Ruidavets JB, McCrum EE. Autres pays, autres coeurs? Dietary patterns, risk factors and ischaemic heart disease in Belfast and Toulouse. Q J Med. 1995;88:469–477
  37. Yarnell JWG. The PRIME study: classical risk factors do not explain the severalfold differences in risk of coronary heart disease between France and Northern Ireland. Q JM. 1998;91:667–676
  38. Elliot RB, Harris DP, Hill JP, Bibby NJ, Wasmuth HE. Type1 (insulin-dependent) diabetes mellitus and cow milk: casein variant consumption. Diabetologia. 1999;42:292–296
  39. Bovenhuis H. The relevance of milk protein polymorphism for cattle breeding. PhD thesis. 1992;
  40. Kritchesky D. Vegetable protein and atherosclerosis. Am J Oil Chem Soc. 1979;56:135–140
  41. Carroll KK. Soya protein and atherosclerosis. J Am Oil Chem Soc. 1981;58:416–419
  42. Terpstra AHM, Herms RJJ, West CE. The role of dietary protein in cholesterol metabolism. World Rev Nutr Diet. 1983;42:1–55
  43. Zhang SH, Reddick RL, Piedrahita JA, Maeda N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 1992;258:468–471
  44. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions at all phases of arteriosclerosis throughout the arterial tree. Arterioscler Thromb. 1994;14:133–140
  45. Weihua N, Tsuda Y, Sakono M, Imaizumi K. Dietary soy protein isolate, compared with casein, reduces atherosclerotic lesion area in apolipoprotein E-deficient mice. J Nutr. 1998;128:1884–1889
  46. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915–924
  47. Heinecke JW. Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall. FASEB J. 1999;13:1113–1120
  48. Torreilles J, Guerin MC. [Casein-derived peptides can promote human LDL oxidation by a peroxidase-dependent and metal independent process] French. Compt Rendu Seances Soc Biol Filial. 1995;189:933–945
  49. Jinsmaa Y, Yoshikawa M. Enzymatic release of neocasomorphin and beta-casomorphin from bovine beta-casein. Peptides. 1999;20:957–962
  50. Jolles P, Levy-Toledano S, Fiat AM. Analogy between fibrinogen and casein. Eur J Biochem. 1986;158:379–382
  51. Fiat A-M, Levy-Tolediano S, Caen JP, Jolles P. Biologically active peptides of casein and lactoferrin implicated in platelet function. J Dairy Res. 1989;56:351–355
  52. Leonil J, Molle D. Liberation of trypic fragments from caseinomacropeptides of bovine κ-casein involved in platelet function; kinetic study. Biochem J. 1990;271:247–252
  53. Masuda O, Nakamura Y, Takano T. Antihypertensive peptides are present in aorta after oral administration of sour milk containing these peptides to spontaneously hypertensive rats. J Nutr. 1996;126:3063–3068
  54. Muehlenkamp MR, Warthesen JJ. β-casomorphins: analysis in cheese and susceptibility to proteolytic enzymes from Lactococcus lactis ssp Cremoris. J Dairy Science. 1996;79:20–26
  55. Jarmolowska B, Kostyra E, Krawczuk S, Kostyra H. β-casomorphin-7 isolated from Brie cheese. J Sci Food Agric. 1999;79:1788–1792
  56. Yamauchi K. Biologically functional proteins of milk and peptides derived from milk proteins. Bulletin IDF. 1992;272:51–58
  57. Hippisley-Cox J, Fielding K, Pringle M. Depression as a risk factor for ischaemic heart disease in men: population based case-control study. BMJ. 1998;316:1714–1719
  58. Kawamoto Y, Namikawa T, Adachi A. A population genetic study on Yaks, cattle and their hybrids in Nepal using milk protein variations. Animal R & Tech. 1992;63:563–575
  59. Page LB, Damon A, Moellering RC. Antecedents of cardiovascular disease in six Solomon Islands societies. Circulation. 1974;49:1132–1146
  60. Taylor R, Lewis ND, Levy S. Societies in transition: mortality patterns in Pacific Island populations. Int J Epid. 1989;18:634–645
  61. Lindeberg S, Nilsson-Ehle P, Terent A, Vessby B, Schersten B. Cardiovascular risk factors in a Melanesian population apparently free from stroke and ischaemic heart disease: the Kitava study. J Intern Med. 1994;23:331–340
  62. Annand JC. Hypothesis: heated milk protein and thrombosis. J Atheroscl. 1967;7:798–801
  63. Thomas EL. Trends in milk flavour. J Dairy Sci. 1981;64:1023–1027
  64. Ostler W. The Lumleian lectures on angina pectoris. Lancet. 1910;1:697–702, 839–844
  65. Benditt EP, Benditt JM. Evidence of a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci USA. 1973;70:1753–1759
  66. Loeb LA, Ernster VL, Warner KE, Abbotts J, Laszlo J. Smoking and lung cancer: an overview. Cancer Res. 1984;44:5940–5958
  67. Doll R, Bradford Hill A. Smoking and carcinoma of the lung: preliminary report. BMJ. 1950;261:739–748
  68. Doll R. Mortality from lung cancer among non- smokers. BMJ. 1953;264:303–312
  69. Clemmesen J, Nielsen A, Jensen E. The increase in incidence of carcinoma of the lung in Denmark, 1931 to 1950. Br J Cancer. 1953;7:1–9
  70. Goodman MT, Hankin JH, Wilkens LR. High-fat foods and the risk of lung cancer. Epidemiology. 1992;3:288–299
  71. Rylander R, Axelsson G, Anderson L, Lilljequist T, Bergman B. Lung cancer, smoking and diet among Swedish men. Lung Cancer. 1996;14:575–845
  72. Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsa M, Carzoglio J. Meat consumption and the risk of lung cancer; a case-control study from Uruguay. Lung Cancer. 1996;14:195–205
  73. Axelsson G, Liljequist T, Andersson L, Bergman B, Rylander R. Dietary factors and lung cancer among men in West Sweden. Int J Epidemiol. 1996;25:32–39
  74. Alavanja MCR, Brownson RC, Benichou J. Estimating the effect of dietary fat on the risk of lung cancer in nonsmoking women. Lung Cancer. 1996;14:S63–S74
  75. Mettlin C. Milk drinking, other beverage habits and lung cancer risk. Int J Cancer. 1989;43:608–612
  76. Sankaranarayan R, Barghese C, Duffy SW, Padmakumary G, Day NE, Nair MK. A case-control study of diet and lung cancer in Kerala, South India. Int J Cancer. 1994;58:644–649
  77. Kalandida A, Katsouyanni K, Voropoulou N. Passive smoking and diet in the etiology of lung cancer among non-smokers. Cancer Cause Control. 1990;1:15–21
  78. Swerdlow AJ, dos Santos SI, Reid A, Qiao Z, Brewster DH, Arundale J. Trends in cancer incidence and mortality in Scotland: description and possible explanations. Br J Cancer. 1998;77:1–54
  79. Makitaro R, Paakko P, Huhti E, Bloigu R, Kinnula VL. An epidemiological study of lung cancer: history and histological types in a general population in northern Finland. Eur Respir J. 1999;13:436–440
  80. Laugesen M, Fraser J. Lung cancer rate falling in women aged 25–54 years. NZ M J1. 1998;350–351
  81. Weiss W. Cigarette smoking and lung cancer trends. Chest. 1997;111:1414–1416
  82. Zatonski WA, McMichael AJ, Powles JW. Ecological study for reasons for sharp decline in mortality from ischaemic heart disease in Poland since 1991. BMJ. 1998;316:1047–1051
  83. Neu A, Kehrer M, Hub R, Ranke MB. Incidence of IDDM in German children aged 0–14 years. Diabetes Care. 1997;20:530–533
  84. Schoenle EJ, Molinari L, Bagot M, Semadeni S, Wiesendanger M. Epidemiology of IDDM in Switzerland. Diabetes Care. 1994;17:955–960

PII: S0306-9877(00)91265-9

doi: 10.1054/mehy.2000.1265

Medical Hypotheses
Volume 56, Issue 2 , Pages 262-272 , February 2001

Article Tools